Schöder Heiko, Ong Seng Chuan
Department of Radiology/Nuclear Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Semin Nucl Med. 2008 Mar;38(2):119-28. doi: 10.1053/j.semnuclmed.2007.11.006.
Molecular imaging allows for the visualization and quantification biologic processes at cellular levels. This article focuses on positron emission tomography as one readily available tool for clinical molecular imaging. To prove its clinical utility in oncology, molecular imaging will ultimately have to provide valuable information in the following 4 pertinent areas: staging; assessment of extent of disease; target delineation for radiation therapy planning; response prediction and assessment and differentiation between treatment sequelae and recurrent disease. These issues are addressed in other contributions in this issue of Seminars in Nuclear Medicine. In contrast, this article will focus on the biochemical principles of cancer metabolism that provide the rationale for positron emission tomography imaging in radiation oncology.
分子成像能够在细胞水平上实现生物过程的可视化和定量分析。本文重点介绍正电子发射断层扫描,它是临床分子成像中一种易于获得的工具。为证明其在肿瘤学中的临床实用性,分子成像最终必须在以下4个相关领域提供有价值的信息:分期;疾病范围评估;放射治疗计划的靶区勾画;反应预测与评估以及治疗后遗症与复发性疾病的鉴别。《核医学研讨会》本期的其他文章中探讨了这些问题。相比之下,本文将重点关注癌症代谢的生化原理,这些原理为放射肿瘤学中的正电子发射断层扫描成像提供了理论依据。